Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q3 2017 call → NOThe question asks whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket — with three conditions: (1) paying now for something not yet earning, (2) the wait is the company's main current work, (3) the far side is a specific, near-dated, already-visible event. Let me scan the transcript for such a situation. Key candidates: - The Portofino launch: "Deliveries of the Portofino, which already has a robust waiting list will commence in 2018." This is a new model, but is there a cost being borne now? Not really described as a cost. - The 812 Superfast: "just arrived in EMEA" — already arriving. - Hybrid technology R&D: "higher R&D expenses for innovation components and hybrid technology." This is R&D spending, but is it described as a defined waiting period with a specific near-dated event? The hybrid is part of the 5-year plan, not a near-dated event within a year. - The Hong Kong dealership: "the new dealership became fully operational in Q3 2017" — that's already done. - F1: not a waiting period. - The patent box: "we've started officially the process with the tax authorities... not expecting anything in the next weeks" — this is a tax benefit, not a cost being borne. Let me look for the specific phenomenon: paying now for something not yet earning, with a near-dated arrival. The Portofino: launched in September, deliveries commence in 2018. But is there a cost being borne? Not described as such. It's a product launch, normal. The hybrid R&D: "you will see a ramp-up" in 2018, "the CapEx will be in my view probably abnormal given what we've been lately." This is future cost, not current cost being borne now with a near-dated arrival. The hybrid is part of the 5-year plan, not a near-dated event within a year. Actually, let me reconsider. The question is very specific: "presently carrying real, ongoing cash or earnings cost for something whose benefit has not arrived yet, AND that the end of that waiting period is a specific, near-dated event." Looking at the transcript, I don't see management describing a current cost being borne for a specific near-dated arrival. The R&D for hybrid is ongoing but the benefit is part of a multi-year plan, not a near-dated event. The Portofino launch is a normal product launch. The Hong Kong dealership is already operational.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.